PLRX:NASDAQ, Pliant Therapeutics, Inc.

PLRX stock overview

Pliant Therapeutics, Inc. (PLRX:NASDAQ) closed at $0.810 on November 6, 2026, down 0.75% on the day. The stock trades 55.4% below its 52-week high of $1.82 and 1.8% above its 52-week low of $0.795. Over the past year, it lost 49.4%. Pliant Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price: $0.810
Day change: -0.75%
Volume: 151,613
Average volume: 394,779
Market cap: 50M+
52-week range: $0.795 – $1.82
50-day average: $1.02
200-day average: $1.15

Price action over the past year

In 252 trading sessions since November 6, 2025, PLRX closed higher on 100 days (40%). Its best day was February 18, 2026 (+10.62%) and its worst was December 4, 2025 (-14.94%). The stock moved 10% or more in a single session 2 times.

Recent signals

Nov 6, 2026: Down 32.5% over 180 days, from $1.20 (Dips & Crashes scanner)
Nov 6, 2026: Trading sideways between $0.810 and $0.890 over 14 days (Sideways scanner)
Nov 6, 2026: Hit a new 52-Week Low of $0.810 (New Highs/Lows scanner)
Oct 29, 2026: News catalyst: Biotech (News Catalysts scanner)

PLRX news

About Pliant Therapeutics, Inc.

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Similar stocks

Find more stocks like PLRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.